Sign in

CIK 0001595097

  • Non-accelerated filer
  • Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464348039
Phone
+1 617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
  1. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $1.85 ($9,234)
  2. 4 Open-market buy Chief Medical Officer bought 10,000 shares at $1.84 ($18,400)
  3. 4 Open-market buy Chief Medical Officer bought 6,000 shares at $1.87 ($11,220)
  4. 4 Open-market buy Chief Executive Officer bought 550 shares at $1.95 ($1,070)
  5. 4 Exercise or conversion Director acquired 10,000 shares (option exercise)
  6. 4 Open-market buy Chief Medical Officer bought 10,000 shares at $2.05 ($20,500)
  7. 4 Open-market sale 10% owner sold 200,000 shares at $3.04 ($607,760)
  8. 4 Open-market buy Chief Financial Officer bought 1,400 shares at $2.06 ($2,879)
  9. 4 Open-market buy Chief Financial Officer bought 1,000 shares at $1.92 ($1,916)
  10. 4 Open-market buy Director bought 8,212 shares at $1.90 ($15,603)
  11. 4 Open-market buy Chief Medical Officer bought 20,000 shares at an average $1.90 ($37,999)
  12. 4 Open-market buy Director bought 10,000 shares at an average $1.89 ($18,945)
  13. 4 Open-market buy Director bought 1,000 shares at $1.92 ($1,919)
  14. 4 Open-market buy Director bought 1,000 shares at $1.90 ($1,900)
  15. 4 Open-market buy Director bought 11,788 shares at an average $1.94 ($22,842)
  16. 4 Open-market buy Chief Executive Officer bought 2,100 shares at an average $1.92 ($4,028)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 15 of 17 · 340 filings